Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.

Commons RJ, Simpson JA, Thriemer K, Abreha T, Adam I, Anstey NM, Assefa A, Awab GR, Baird JK, Barber BE, Chu CS, Dahal P, Daher A, Davis TME, Dondorp AM, Grigg MJ, Humphreys GS, Hwang J, Karunajeewa H, Laman M, Lidia K, Moore BR, Mueller I, Nosten F, Pasaribu AP, Pereira DB, Phyo AP, Poespoprodjo JR, Sibley CH, Stepniewska K, Sutanto I, Thwaites G, Hien TT, White NJ, William T, Woodrow CJ, Guerin PJ, Price RN.

PLoS Med. 2019 Oct 4;16(10):e1002928. doi: 10.1371/journal.pmed.1002928. eCollection 2019 Oct.

2.

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.

Commons RJ, Simpson JA, Thriemer K, Chu CS, Douglas NM, Abreha T, Alemu SG, Añez A, Anstey NM, Aseffa A, Assefa A, Awab GR, Baird JK, Barber BE, Borghini-Fuhrer I, D'Alessandro U, Dahal P, Daher A, de Vries PJ, Erhart A, Gomes MSM, Grigg MJ, Hwang J, Kager PA, Ketema T, Khan WA, Lacerda MVG, Leslie T, Ley B, Lidia K, Monteiro WM, Pereira DB, Phan GT, Phyo AP, Rowland M, Saravu K, Sibley CH, Siqueira AM, Stepniewska K, Taylor WRJ, Thwaites G, Tran BQ, Hien TT, Vieira JLF, Wangchuk S, Watson J, William T, Woodrow CJ, Nosten F, Guerin PJ, White NJ, Price RN.

BMC Med. 2019 Aug 1;17(1):151. doi: 10.1186/s12916-019-1386-6.

3.

Forces acting on codon bias in malaria parasites.

Sinha I, Woodrow CJ.

Sci Rep. 2018 Oct 29;8(1):15984. doi: 10.1038/s41598-018-34404-9.

4.

Correction to: Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.

Srimuang K, Miotto O, Lim P, Fairhurst RM, Kwiatkowski DP, Woodrow CJ, Imwong M; Tracking Resistance to Artemisinin Collaboration.

Malar J. 2018 Sep 10;17(1):325. doi: 10.1186/s12936-018-2464-5.

5.

The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.

Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, Añez A, Anstey NM, Awab GR, Baird JK, Barber BE, Borghini-Fuhrer I, Chu CS, D'Alessandro U, Dahal P, Daher A, de Vries PJ, Erhart A, Gomes MSM, Gonzalez-Ceron L, Grigg MJ, Heidari A, Hwang J, Kager PA, Ketema T, Khan WA, Lacerda MVG, Leslie T, Ley B, Lidia K, Monteiro WM, Nosten F, Pereira DB, Phan GT, Phyo AP, Rowland M, Saravu K, Sibley CH, Siqueira AM, Stepniewska K, Sutanto I, Taylor WRJ, Thwaites G, Tran BQ, Tran HT, Valecha N, Vieira JLF, Wangchuk S, William T, Woodrow CJ, Zuluaga-Idarraga L, Guerin PJ, White NJ, Price RN.

Lancet Infect Dis. 2018 Sep;18(9):1025-1034. doi: 10.1016/S1473-3099(18)30348-7. Epub 2018 Jul 20.

6.

Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum.

Bopp S, Magistrado P, Wong W, Schaffner SF, Mukherjee A, Lim P, Dhorda M, Amaratunga C, Woodrow CJ, Ashley EA, White NJ, Dondorp AM, Fairhurst RM, Ariey F, Menard D, Wirth DF, Volkman SK.

Nat Commun. 2018 May 2;9(1):1769. doi: 10.1038/s41467-018-04104-z.

7.

Malaria.

Ashley EA, Pyae Phyo A, Woodrow CJ.

Lancet. 2018 Apr 21;391(10130):1608-1621. doi: 10.1016/S0140-6736(18)30324-6. Epub 2018 Apr 6. Review.

PMID:
29631781
8.

Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.

Awab GR, Imwong M, Bancone G, Jeeyapant A, Day NPJ, White NJ, Woodrow CJ.

Am J Trop Med Hyg. 2017 Dec;97(6):1782-1787. doi: 10.4269/ajtmh.17-0290. Epub 2017 Oct 26.

9.

Pfhrp2 Deletions in the Democratic Republic of Congo: Evidence of Absence, or Absence of Evidence?

Woodrow CJ, Fanello C.

J Infect Dis. 2017 Aug 15;216(4):504-506. doi: 10.1093/infdis/jix345. No abstract available.

10.

Plasmodium vivax genetic diversity and heterozygosity in blood samples and resulting oocysts at the Thai-Myanmar border.

Soontarawirat I, Andolina C, Paul R, Day NPJ, Nosten F, Woodrow CJ, Imwong M.

Malar J. 2017 Sep 5;16(1):355. doi: 10.1186/s12936-017-2002-x.

11.

Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis.

Ndour PA, Larréché S, Mouri O, Argy N, Gay F, Roussel C, Jauréguiberry S, Perillaud C, Langui D, Biligui S, Chartrel N, Mérens A, Kendjo E, Ghose A, Hassan MMU, Hossain MA, Kingston HWF, Plewes K, Dondorp AM, Danis M, Houzé S, Bonnefoy S, Thellier M, Woodrow CJ, Buffet PA; French Artesunate Working Group.

Sci Transl Med. 2017 Jul 5;9(397). pii: eaaf9377. doi: 10.1126/scitranslmed.aaf9377.

PMID:
28679662
12.

Antimalarial Resistance Unlikely To Explain U.K. Artemether-Lumefantrine Failures.

van der Pluijm RW, Watson J, Woodrow CJ.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00721-17. doi: 10.1128/AAC.00721-17. Print 2017 Jul. No abstract available.

13.

Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria.

Plewes K, Soontarawirat I, Ghose A, Bancone G, Kingston HWF, Herdman MT, Leopold SJ, Ishioka H, Faiz MA, Anstey NM, Day NPJ, Hossain MA, Imwong M, Dondorp AM, Woodrow CJ.

Malar J. 2017 Mar 29;16(1):134. doi: 10.1186/s12936-017-1788-x.

14.

Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.

Srimuang K, Miotto O, Lim P, Fairhurst RM, Kwiatkowski DP, Woodrow CJ, Imwong M; Tracking Resistance to Artemisinin Collaboration.

Malar J. 2016 Nov 8;15(1):541. doi: 10.1186/s12936-016-1598-6. Erratum in: Malar J. 2018 Sep 10;17(1):325.

15.

Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia.

Grist EP, Flegg JA, Humphreys G, Mas IS, Anderson TJ, Ashley EA, Day NP, Dhorda M, Dondorp AM, Faiz MA, Gething PW, Hien TT, Hlaing TM, Imwong M, Kindermans JM, Maude RJ, Mayxay M, McDew-White M, Menard D, Nair S, Nosten F, Newton PN, Price RN, Pukrittayakamee S, Takala-Harrison S, Smithuis F, Nguyen NT, Tun KM, White NJ, Witkowski B, Woodrow CJ, Fairhurst RM, Sibley CH, Guerin PJ.

Int J Health Geogr. 2016 Oct 24;15(1):37.

16.

The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.

Woodrow CJ, White NJ.

FEMS Microbiol Rev. 2017 Jan;41(1):34-48. doi: 10.1093/femsre/fuw037. Epub 2016 Sep 8. Review.

17.

Reply to Meshnick and Hastings et al.

Phyo AP, Ashley EA, Anderson TJ, Carrara VI, Woodrow CJ, White NJ, Nosten F.

Clin Infect Dis. 2016 Dec 1;63(11):1528-1529. Epub 2016 Aug 23. No abstract available.

18.

Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.

Phyo AP, Ashley EA, Anderson TJC, Bozdech Z, Carrara VI, Sriprawat K, Nair S, White MM, Dziekan J, Ling C, Proux S, Konghahong K, Jeeyapant A, Woodrow CJ, Imwong M, McGready R, Lwin KM, Day NPJ, White NJ, Nosten F.

Clin Infect Dis. 2016 Sep 15;63(6):784-791. doi: 10.1093/cid/ciw388. Epub 2016 Jun 16.

19.

Erratum to: K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.

Win AA, Imwong M, Kyaw MP, Woodrow CJ, Chotivanich K, Hanboonkunupakarn B, Pukrittayakamee S.

Malar J. 2016 May 27;15(1):297. No abstract available.

20.

Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study.

Tun KM, Jeeyapant A, Imwong M, Thein M, Aung SS, Hlaing TM, Yuentrakul P, Promnarate C, Dhorda M, Woodrow CJ, Dondorp AM, Ashley EA, Smithuis FM, White NJ, Day NP.

Malar J. 2016 Mar 31;15:185. doi: 10.1186/s12936-016-1240-7.

21.

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.

Awab GR, Imwong M, Pukrittayakamee S, Alim F, Hanpithakpong W, Tarning J, Dondorp AM, Day NP, White NJ, Woodrow CJ.

Malar J. 2016 Feb 25;15:121. doi: 10.1186/s12936-016-1167-z.

22.

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.

Win AA, Imwong M, Kyaw MP, Woodrow CJ, Chotivanich K, Hanboonkunupakarn B, Pukrittayakamee S.

Malar J. 2016 Feb 24;15:110. doi: 10.1186/s12936-016-1147-3. Erratum in: Malar J. 2016;15(1):297.

23.

Use of Blood Smears and Dried Blood Spots for Polymerase Chain Reaction-Based Detection and Quantification of Bacterial Infection and Plasmodium falciparum in Severely Ill Febrile African Children.

Wihokhoen B, Dondorp AM, Turner P, Woodrow CJ, Imwong M.

Am J Trop Med Hyg. 2016 Feb;94(2):322-326. doi: 10.4269/ajtmh.15-0532. Epub 2015 Dec 28.

24.

Exploring health practitioners' acceptability of a prospective semi-quantitative pfHRP2 device to define severe malaria in the Democratic Republic of Congo.

de Haan F, Onyamboko MA, Fanello CI, Woodrow CJ, Lubell Y, Boon WP, Dondorp AM.

Malar J. 2015 Dec 15;14:503. doi: 10.1186/s12936-015-0963-1.

25.

Erratum to: the role of previously unmeasured organic acids in the pathogenesis of severe malaria.

Herdman MT, Sriboonvorakul N, Leopold SJ, Douthwaite S, Mohanty S, Hassan MM, Maude RJ, Kingston HW, Plewes K, Charunwatthana P, Silamut K, Woodrow CJ, Ghose A, Chotinavich K, Hossain MA, Faiz MA, Mishra S, Leepipatpiboon N, White NJ, Day NP, Tarning J, Dondorp AM.

Crit Care. 2015 Nov 2;19:382. doi: 10.1186/s13054-015-1116-1. No abstract available.

26.

Use of a rapid test to assess plasma Plasmodium falciparum HRP2 and guide management of severe febrile illness.

Sinha I, Ekapirat N, Dondorp AM, Woodrow CJ.

Malar J. 2015 Sep 22;14:362. doi: 10.1186/s12936-015-0900-3.

27.

The role of previously unmeasured organic acids in the pathogenesis of severe malaria.

Herdman MT, Sriboonvorakul N, Leopold SJ, Douthwaite S, Mohanty S, Hassan MM, Maude RJ, Kingston HW, Plewes K, Charunwatthana P, Silamut K, Woodrow CJ, Ghose A, Chotinavich K, Hossain MA, Faiz MA, Mishra S, Leepipatpiboon N, White NJ, Day NP, Tarning J, Dondorp AM.

Crit Care. 2015 Sep 7;19:317. doi: 10.1186/s13054-015-1023-5. Erratum in: Crit Care. 2015;19:382. Ghose, Aniruddha [added].

28.

Artemisinin resistance in Myanmar--Authors' reply.

Imwong M, Tun KM, Hlaing TM, Grist EP, Guerin P, Smithuis F, Dondorp AM, Day NP, Nosten F, White N, Woodrow CJ.

Lancet Infect Dis. 2015 Sep;15(9):1002-1003. doi: 10.1016/S1473-3099(15)00248-0. No abstract available.

PMID:
26333325
29.

Comparison between Flow Cytometry, Microscopy, and Lactate Dehydrogenase-Based Enzyme-Linked Immunosorbent Assay for Plasmodium falciparum Drug Susceptibility Testing under Field Conditions.

Woodrow CJ, Wangsing C, Sriprawat K, Christensen PR, Nosten F, Rénia L, Russell B, Malleret B.

J Clin Microbiol. 2015 Oct;53(10):3296-303. doi: 10.1128/JCM.01226-15. Epub 2015 Aug 12.

30.

Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.

Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, Lin K, Kyaw MP, Plewes K, Faiz MA, Dhorda M, Cheah PY, Pukrittayakamee S, Ashley EA, Anderson TJ, Nair S, McDew-White M, Flegg JA, Grist EP, Guerin P, Maude RJ, Smithuis F, Dondorp AM, Day NP, Nosten F, White NJ, Woodrow CJ.

Lancet Infect Dis. 2015 Apr;15(4):415-21. doi: 10.1016/S1473-3099(15)70032-0. Epub 2015 Feb 20.

31.

Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance.

Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, Chotivanich K, Imwong M, Pukrittayakamee S, Dhorda M, Nguon C, Lim P, Amaratunga C, Suon S, Hien TT, Htut Y, Faiz MA, Onyamboko MA, Mayxay M, Newton PN, Tripura R, Woodrow CJ, Miotto O, Kwiatkowski DP, Nosten F, Day NP, Preiser PR, White NJ, Dondorp AM, Fairhurst RM, Bozdech Z.

Science. 2015 Jan 23;347(6220):431-5. doi: 10.1126/science.1260403. Epub 2014 Dec 11.

32.

Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.

White NJ, Ashley EA, Recht J, Delves MJ, Ruecker A, Smithuis FM, Eziefula AC, Bousema T, Drakeley C, Chotivanich K, Imwong M, Pukrittayakamee S, Prachumsri J, Chu C, Andolina C, Bancone G, Hien TT, Mayxay M, Taylor WR, von Seidlein L, Price RN, Barnes KI, Djimdé A, ter Kuile F, Gosling R, Chen I, Dhorda MJ, Stepniewska K, Guérin P, Woodrow CJ, Dondorp AM, Day NP, Nosten FH.

Malar J. 2014 Dec 9;13:483. doi: 10.1186/1475-2875-13-483. Review.

33.

Plasma concentration of parasite DNA as a measure of disease severity in falciparum malaria.

Imwong M, Woodrow CJ, Hendriksen IC, Veenemans J, Verhoef H, Faiz MA, Mohanty S, Mishra S, Mtove G, Gesase S, Seni A, Chhaganlal KD, Day NP, Dondorp AM, White NJ.

J Infect Dis. 2015 Apr 1;211(7):1128-33. doi: 10.1093/infdis/jiu590. Epub 2014 Oct 24.

34.

Parasite burden and severity of malaria in Tanzanian children.

Woodrow CJ, Dondorp AM.

N Engl J Med. 2014 Jul 31;371(5):481-2. doi: 10.1056/NEJMc1407114. No abstract available.

PMID:
25075850
35.

Spread of artemisinin resistance in Plasmodium falciparum malaria.

Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ; Tracking Resistance to Artemisinin Collaboration (TRAC).

N Engl J Med. 2014 Jul 31;371(5):411-23. doi: 10.1056/NEJMoa1314981. Erratum in: N Engl J Med. 2014 Aug 21;371(8):786.

36.

A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan.

Jamornthanyawat N, Awab GR, Tanomsing N, Pukrittayakamee S, Yamin F, Dondorp AM, Day NP, White NJ, Woodrow CJ, Imwong M.

PLoS One. 2014 Feb 21;9(2):e88605. doi: 10.1371/journal.pone.0088605. eCollection 2014.

37.

Field-based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivity.

Russell B, Malleret B, Suwanarusk R, Anthony C, Kanlaya S, Lau YL, Woodrow CJ, Nosten F, Renia L.

Antimicrob Agents Chemother. 2013 Oct;57(10):5170-4. doi: 10.1128/AAC.00682-13. Epub 2013 Jul 22.

38.

High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.

Woodrow CJ, Dahlström S, Cooksey R, Flegg JA, Le Nagard H, Mentré F, Murillo C, Ménard D, Nosten F, Sriprawat K, Musset L, Quashie NB, Lim P, Fairhurst RM, Nsobya SL, Sinou V, Noedl H, Pradines B, Johnson JD, Guerin PJ, Sibley CH, Le Bras J.

Antimicrob Agents Chemother. 2013 Jul;57(7):3121-30. doi: 10.1128/AAC.02350-12. Epub 2013 Apr 22.

39.

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.

Awab GR, Pukrittayakamee S, Jamornthanyawat N, Yamin F, Dondorp AM, Day NP, White NJ, Woodrow CJ, Imwong M.

Malar J. 2013 Mar 15;12:96. doi: 10.1186/1475-2875-12-96.

40.

Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria.

Ramutton T, Hendriksen IC, Mwanga-Amumpaire J, Mtove G, Olaosebikan R, Tshefu AK, Onyamboko MA, Karema C, Maitland K, Gomes E, Gesase S, Reyburn H, Silamut K, Chotivanich K, Promnares K, Fanello CI, von Seidlein L, Day NP, White NJ, Dondorp AM, Imwong M, Woodrow CJ.

Malar J. 2012 Aug 16;11:276. doi: 10.1186/1475-2875-11-276.

41.

Reappraisal of the efficacy of a simplified artesunate regimen in falciparum malaria.

Woodrow CJ, Taylor WR.

J Infect Dis. 2012 Aug 15;206(4):619-21; author reply 622. doi: 10.1093/infdis/jis390. Epub 2012 Jun 25. No abstract available.

42.

Questions over high frequency of mutant PfATP6 haplotypes in traveller isolates.

Woodrow CJ, Gardner KB, Bustamante LY.

Malar J. 2012 Jun 8;11:186. doi: 10.1186/1475-2875-11-186.

43.

Protein-based signatures of functional evolution in Plasmodium falciparum.

Gardner KB, Sinha I, Bustamante LY, Day NP, White NJ, Woodrow CJ.

BMC Evol Biol. 2011 Sep 14;11:257. doi: 10.1186/1471-2148-11-257.

44.

Artemisinin Antimalarials: Preserving the "Magic Bullet"

Maude RJ, Woodrow CJ, White LJ.

Drug Dev Res. 2010 Feb;71(1):12-19.

45.

Mechanisms of artemisinin action and resistance: wider focus is needed.

Woodrow CJ, Bustamante LY.

Trends Parasitol. 2011 Jan;27(1):2-3; author reply 3-4. doi: 10.1016/j.pt.2010.10.002. Epub 2010 Nov 5. No abstract available.

PMID:
21115398
46.

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ; AQUAMAT group.

Lancet. 2010 Nov 13;376(9753):1647-57. doi: 10.1016/S0140-6736(10)61924-1. Epub 2010 Nov 7. Erratum in: Lancet. 2011 Jan 8;377(9760):126.

47.

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.

Awab GR, Pukrittayakamee S, Imwong M, Dondorp AM, Woodrow CJ, Lee SJ, Day NP, Singhasivanon P, White NJ, Kaker F.

Malar J. 2010 Apr 21;9:105. doi: 10.1186/1475-2875-9-105.

48.

Plasmodium falciparum ATP6 not under selection during introduction of artemisinin combination therapy in Peru.

Woodrow CJ, Bustamante LY.

Antimicrob Agents Chemother. 2010 May;54(5):2280; author reply 2280-1. doi: 10.1128/AAC.01341-09. No abstract available.

49.

Computational analysis of binding between malarial dihydrofolate reductases and anti-folates.

Choowongkomon K, Theppabutr S, Songtawee N, Day NP, White NJ, Woodrow CJ, Imwong M.

Malar J. 2010 Mar 2;9:65. doi: 10.1186/1475-2875-9-65.

50.

Identification, expression and characterisation of a Babesia bovis hexose transporter.

Derbyshire ET, Franssen FJ, de Vries E, Morin C, Woodrow CJ, Krishna S, Staines HM.

Mol Biochem Parasitol. 2008 Oct;161(2):124-9. doi: 10.1016/j.molbiopara.2008.06.010. Epub 2008 Jun 27.

Supplemental Content

Loading ...
Support Center